Status:
COMPLETED
Ropivacaine Though Laterosternal Catheters After Cardiac Surgery
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Cardiac Surgery
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
This is a prospective double-blinded and randomised study involving patients undergoing cardiac surgery with median sternotomy, the effects on postoperative analgesia of a 48-hr continuous infusion of...
Detailed Description
Diverse methods for infusion of local anaesthetics after cardiac surgery have been proposed, but none of them provided high-level evidence of efficacy. The catheters studied here are designed for a su...
Eligibility Criteria
Inclusion
- Scheduled cardiac surgery.
Exclusion
- \- surgery in emergency
- thoracotomy
- cardiac graft
- redo
- pregnancy
- patient's refusal
- minor or adult under legal protection
- psychiatric ongoing disease
- addiction to opiates
- ongoing opiate treatment
- inability to use a PCA device
- respiratory insuffiency (Vital capacity or maximal expired volume per sec. \< 50% of the expected value, or mean PAP \> 50 mmHg)
- intra-aortic balloon
- severe renal insuffiency
- history of allergy or intolerance to: morphine, acetaminophen, bupivacaine.
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01196767
Start Date
July 1 2010
End Date
November 1 2010
Last Update
April 4 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, France, 63003